[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Formulating data for meta-analyses",
    "section": "",
    "text": "This is the website for the second practical of the Training School – Impact of Meta-analyses on Clinical Practice."
  },
  {
    "objectID": "part_a.html",
    "href": "part_a.html",
    "title": "Part A",
    "section": "",
    "text": "Question 1\n\nWhat is the objective of the systematic review and what were the main findings?"
  },
  {
    "objectID": "part_a.html#formulate-the-review-question",
    "href": "part_a.html#formulate-the-review-question",
    "title": "Part A",
    "section": "Formulate the review question",
    "text": "Formulate the review question\n\n\nQuestion 2\n\nWhich is the population under study in this review?\n\nHow is the disease/condition defined?\nWhat are the most important characteristics that describe these people?\nAre there any relevant demographic factors (e.g. age, sex, ethnicity)?\nAre there other types of people who should be excluded from the review?\n\n\n\n\nQuestion 3\n\nWhich are the interventions of the review?\n\n\n\nQuestion 4\n\nWhich are the comparisons of the review?\n\n\n\nQuestion 5\n\nWhich are the outcomes considered in this review?"
  },
  {
    "objectID": "part_a.html#plan-eligibility-criteria",
    "href": "part_a.html#plan-eligibility-criteria",
    "title": "Part A",
    "section": "Plan eligibility criteria",
    "text": "Plan eligibility criteria\n\n\nQuestion 6\n\nWhich studies should be excluded from the search?"
  },
  {
    "objectID": "part_a.html#search-for-potentially-relevant-studies",
    "href": "part_a.html#search-for-potentially-relevant-studies",
    "title": "Part A",
    "section": "Search for potentially relevant studies",
    "text": "Search for potentially relevant studies\n\n\nQuestion 7\n\nWhich study designs are included? What about ongoing trials?\n\n\n\nQuestion 8\n\nWhich databases were considered for conducting the review? Look at the search terms of Appendix 1 for the case of CENTRAL. Can you describe what the search is about?"
  },
  {
    "objectID": "part_a.html#collect-data",
    "href": "part_a.html#collect-data",
    "title": "Part A",
    "section": "Collect data",
    "text": "Collect data\n\n\nQuestion 10\n\nCollection of data\n\nWhat are the key data reported regarding the included studies?"
  },
  {
    "objectID": "part_a.html#select-eligible-studies",
    "href": "part_a.html#select-eligible-studies",
    "title": "Part A",
    "section": "Select eligible studies",
    "text": "Select eligible studies\n\n\nQuestion 9\n\nExtraction results:\n\nHow many studies were identified in total?\nHow many of those were ultimately considered for further analyses?\nWhat were the reasons for excluding the rest of the trials?"
  },
  {
    "objectID": "part_b.html",
    "href": "part_b.html",
    "title": "Part B",
    "section": "",
    "text": "Question 1\n\nImport the data and explain what they are about.\n\n\n\nQuestion 2\n\nHow many studies compare celecoxib to placebo with regard to pain in less than 24 weeks?\n\n\n\nQuestion 3\n\nIn total, how many patients received celecoxib and how many received placebo in the studies comparing these two treatments with regard to pain in less than 24 weeks?\n\n\n\nQuestion 4\n\nWhat was the average level of pain in less than 24 weeks in the celecoxib and the placebo patients?\n\n\n\nQuestion 5\n\nFor how many studies comparing celecoxib to placebo with regard to pain in less than 24 weeks do we not have information on the year they were conducted?\n\n\n\nQuestion 6\n\nWhat is the earliest, latest and median publication year of the studies comparing celecoxib to placebo with regard to all pain in less than 24 weeks, if we disregard any missing information?\n\n\n\nQuestion 7\n\nWhat is the relative treatment effect of the study with id “STD-Asmus-2014-Study-1”?\n\n\n\nQuestion 8\n\nHow many studies compare celecoxib to placebo with regard to number of adverse events ?\n\n\n\nQuestion 9\n\nIn total, how many patients received celecoxib and how many received placebo in the studies comparing these two treatments with regard to number of adverse events?\n\n\n\nQuestion 10\n\nWhat was the average number of adverse events in the celecoxib and the placebo patients?\n\n\n\nQuestion 11\n\nWhat is the relative treatment effect of the study with id “STD-Asmus-2014-Study-1”?"
  },
  {
    "objectID": "index.html#part-a",
    "href": "index.html#part-a",
    "title": "Formulating data for meta-analyses",
    "section": "Part A",
    "text": "Part A\nFor the completion of Part A you will need to download the Cochrane systematic review from here"
  },
  {
    "objectID": "index.html#part-b",
    "href": "index.html#part-b",
    "title": "Formulating data for meta-analyses",
    "section": "Part B",
    "text": "Part B\nFor the completion of Part B you will need to download the data (csv file) from here"
  }
]